GLAXONSEGlaxoSmithKline Pharmaceuticals Limited· PharmaceuticalsLowNeutral
Announced Wed, 13 May · 19:35 IST

GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Link of Recording

Investor Communications View source PDF

GLAXO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+1.2%1-day move
₹2410.00
prior close
₹2437.10
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.5+0.7+0.2-0.9+1.2-0.8-0.9-2.6-4.0-4.6-10.2-12.2+2.3
Up moveDown movePending
AI summary

GlaxoSmithKline Pharmaceuticals Limited has informed the stock exchanges (BSE and NSE) that a recording of analyst and institutional investor meetings has been uploaded to their investor relations portal. This disclosure is made under SEBI's Regulation 30 and Part A of Schedule III of the Listing Obligations and Disclosure Requirements Regulations, 2015. The company has provided a link to the audio/video file on their website. The filing is dated 13th May 2026 and signed by Ajay Nadkarni, Vice President - Administration, Real Estate & Company Secretary. The actual content of the analyst meeting recording is not included in this filing itself.

Likely market impact

This is a routine regulatory disclosure informing investors that an analyst meeting recording is available for viewing. The filing itself does not contain specific details about discussions or new information, so it is unlikely to have an immediate impact on the stock price.